In recent BCI news, neurotechnology, and specifically brain-computer interfaces (BCIs), have been gaining significant prevalence in public discourse. Studies demonstrating BCI capabilities, once solely found in academic journals, are now frequently covered in mainstream and business publications, alongside think pieces about what BCI could mean for society. Notable examples of this BCI news coverage include:

• “Brain Implant Allows Fully Paralyzed Patient to Communicate” (The New York Times) 
• “Tapping in to the Brain to Help a Paralyzed Man Speak” (The New York Times) 
• “Paralysed man uses ‘mindwriting’ brain computer to compose sentences” (The Guardian) 
• “Tiny Brain Implants Hold Big Promise for Immobilized Patients” (The Wall Street Journal)
• “What Brain-Computer Interfaces Could Mean for the Future of Work” (Harvard Business Review)

Also indicated by recent BCI news is a significant investment boom in the space. BCI start-ups raised $531 million in venture funding in 2021 alone, nearly four times the amount in 2020. As one of the top BCI makers, Paradromics announced a $20 million seed fund round led by Prime Movers Lab in July 2021, with our total funding now reaching $38 million in venture funding and $18 million in public funding from NIH and DARPA.

Investors plunked $531 million into brain-computing startups in 2021, nearly four times the amount in 2020. (Fortune)

BCI for Medical Needs: Delivering Healthtech Solutions

Paradromics is developing a data-driven BCI-based technology for brain health. Our BCI provides both the high data rate and the proximity to brain signals required for advanced medical applications. We are intent on leveraging the vast brain data that we can access with our platform to solve difficult neurological and brain-related medical challenges. This mission is in-line with current public thinking on implantable BCI according to recent Pew polling indicating wide acceptance for therapeutic use.

A large share of Americans (77%) say they would favor the use of computer implants in the brain to allow increased movement for people who are paralyzed. Just 8% would oppose this use, while 14% say they aren’t sure. (Pew Research Center)

Our first clinical application is an assistive communication device for patients who’ve lost the physical ability to speak or type–essentially transforming their neural data into text or synthesized speech. However, potential future applications could range from restoring movement or sensation to people with sensory or motor deficits to detecting and treating intractable mental illness.

Paradromics takes the lead as one of the top BCI makers

Paradromics is focused on using neurotechnology to help people regain daily function and connection with the world. For us, the most exciting future is one where sensory deficits, paralysis, and mental health are all considered treatable conditions, reflecting our commitment to advanced healthtech solutions.

While the potential for BCI extends far beyond medicine, a strong commitment to healthcare outcomes lies at the center of our approach, both from a technical and business perspective. We are following a traditional surgical model, with neurosurgeons performing the procedures to place the devices into patients. This approach ensures the best possible outcomes for patients; this is why surgically implanted high bandwidth interfaces are preferable for data-intensive healthcare applications, as opposed to less invasive alternatives.

Recognizing that neurosurgery, whether performed by a human or a robot, is not to be taken lightly, we are focusing on a robust design and biocompatible materials to support long-term implantation for use in a patient’s everyday life. In choosing materials and processes, we have pursued the most proven and durable options. As with all implantable medical devices, clinicians are involved in setting the requirements for the devices and their surgical implantation, and the FDA provides specific guidance for testing and safety, ensuring our healthtech solutions meet the highest standards.

Follow us on our website or on LinkedIn to keep track of the latest BCI News

As BCI grows in the public consciousness and soon moves into clinical trials, we feel it’s important to share our knowledge about the key concepts in developing these devices and the applications that we foresee for this technology. Look for upcoming blogs and news articles covering important topics live assistive communication, other potential medical applications, and related ethical considerations. We will also publish future blogs on the material and design requirements for these medical devices, along with details of some of the technical advancements that make these devices possible.